Based on this knowledge, Signorelli et al. investigated the plasma levels of inflammatory markers such as interleukin (IL)-6 and tumor necrosis factor (TNF)-α in patients with PAD and in healthy controls [126]. This evidence concerns the gene TNF and peripheral arterial disease.